Opioid prescribing for cancer pain during the last 3 months of life: Associated factors and 9-year trends in a nationwide United Kingdom cohort study

Journal of Clinical Oncology

Volumn 30, Issue 35, 2012, Pages 4373-4379

  Higginson, Irene J ^a   Gao, Wei ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; BUPRENORPHINE; DEXTROMORAMIDE; DIAMORPHINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; PETHIDINE; PHENAZOCINE; SUFENTANIL;

ADULT; AGED; ANALGESIA; ARTICLE; BREAST CANCER; CANCER PAIN; CANCER PATIENT; COLORECTAL CANCER; FEMALE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; TREND STUDY; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; COHORT STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF LIFE;

EID: 84870729402     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.0919     Document Type: Article

References (40)

1. Foley KM: How well is cancer pain treated? Palliat Med 25:398-401, 2011
2. Bernabei R, Gambassi G, Lapane K, et al: Management of pain in elderly patients with cancer: SAGE Study Group - Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 279:1877-1882, 1998
3. Cherny NI, Baselga J, de Conno F, et al: Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: A report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol 21:615-626, 2010
4. Higginson IJ, Hearn J, Murtagh F: Epidemiology of cancer pain, in Sykes N, Bennett MI, Yuan C-S (eds): Clinical Pain Management: Cancer Pain (ed 2). London, United Kingdom, Hodder Arnold, 2008, pp 13-26
5. Costantini M, Ripamonti C, Beccaro M, et al: Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients' life: Results of an Italian mortality follow-back survey. Ann Oncol 20:729-735, 2009
6. Deandrea S, Montanari M, Moja L, et al: Prevalence of undertreatment in cancer pain: A review of published literature. Ann Oncol 19:1985-1991, 2008
7. Portenoy RK: Treatment of cancer pain. Lancet 377:2236-2247, 2011
8. Foley KM, Portenoy RK: World Health Organization-International Association for the Study of Pain: Joint initiatives in Cancer Pain Relief. J Pain Symptom Manage 8:335-339, 1993 (Pubitemid 23239214)
9. Grond S, Zech D, Schug SA, et al: Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 6:411-422, 1991
10. Dy SM, Shugarman LR, Lorenz KA, et al: A systematic review of satisfaction with care at the end of life. J Am Geriatr Soc 56:124-129, 2008
11. Swarm R, Abernethy AP, Anghelescu DL, et al: Adult cancer pain. J Natl Compr Canc Netw 8:1046-1086, 2010
12. Fainsinger RL, Fairchild A, Nekolaichuk C, et al: Is pain intensity a predictor of the complexity of cancer pain management? J Clin Oncol 27:585-590, 2009
13. Liberman J, O'Brien M, Hall W, et al: Ending inequities in access to effective pain relief? Lancet 376:856-857, 2010
14. Jarlbaek L, Hansen DG, Bruera E, et al: Frequency of opioid use in a population of cancer patients during the trajectory of the disease. Clin Oncol (R Coll Radiol) 22:199-207, 2010
15. US Food and Drug Administration: Risk Evaluation and Mitigation Strategy (REMS) for extended-release and long-lasting opioids. http://www.fda.gov/Drugs/ DrugSafety/InformationbyDrugClass/ucm163647.htm
16. Lewis JD, Schinnar R, Bilker WB, et al: Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 16:393-401, 2007 (Pubitemid 46656860)
17. Charlton RA, Cunnington MC, de Vries CS, et al: Data resources for investigating drug exposure during pregnancy and associated outcomes: The General Practice Research Database (GPRD) as an alternative to pregnancy registries. Drug Saf 31:39-51, 2008
18. García Rodríguez LA, Pérez Gutthann S: Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 45:419-425, 1998
19. The Information Centre: Hospital prescribing, 2005: England. http://www.ic.nhs.uk/webfiles/publications/hospres05/ ReportOfHospitalPrescribing291106-PDF.pdf
20. Department of Health: Safer management of controlled drugs: A guide to good practice in secondary care (England). London, United Kingdom, Department of Health and Royal Pharmaceutical Society of Great Britain, 2007
21. National Prescribing Centre (NPC): A guide to good practice in the management of controlled drugs in primary care (ed 3). London, United Kingdom, National Health Service, NPC, 2009
22. Walley T, Mantgani A: The UK General Practice Research Database. Lancet 350:1097-1099, 1997 (Pubitemid 27437871)
23. Zech DF, Grond S, Lynch J, et al: Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain 63:65-76, 1995
24. Khan NF, Perera R, Harper S, et al: Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract 11:1, 2010
25. Breuer B, Fleishman SB, Cruciani RA, et al: Medical oncologists' attitudes and practice in cancer pain management: A national survey. J Clin Oncol 29:4769-4775, 2011
26. Volkow ND, McLellan TA, Cotto JH, et al: Characteristics of opioid prescriptions in 2009. JAMA 305:1299-1301, 2011
27. Klepstad P, Kaasa S, Cherny N, et al: Pain and pain treatments in European palliative care units: A cross sectional survey from the European Association for Palliative Care Research Network. Palliat Med 19:477-484, 2005 (Pubitemid 41430821)
28. Twycross RG: Choice of strong analgesic in terminal cancer: Diamorphine or morphine? Pain 3:93-104, 1977
29. Barclay S, Todd C, Grande G, et al: Controlling cancer pain in primary care: The prescribing habits and knowledge base of general practitioners. J Pain Symptom Manage 23:383-392, 2002 (Pubitemid 34463007)
30. Caraceni A, Pigni A, Brunelli C: Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project. Palliat Med 25:402-409, 2011
31. Okie S: A flood of opioids, a rising tide of deaths. N Engl J Med 363:1981-1985, 2010
32. Caraceni A, Hanks G, Kaasa S, et al: Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol 13:e58-e68, 2012
33. National Institute for Health and Clinical Excellence (NICE): Opioids in palliative care: Safe and effective prescribing of strong opioids for pain in palliative care of adults. NICE clinical guideline 140, May 2012. http://www.nice.org.uk/nicemedia/live/13745/59285/59285.pdf
34. Gao W, Gulliford M, Higginson IJ: Prescription patterns of analgesics in the last 3 months of life: A retrospective analysis of 10202 lung cancer patients. Br J Cancer 104:1704-1710, 2011
35. Viganó A, Bruera E, Suarez-Almazor ME: Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer 83:1244-1250, 1998 (Pubitemid 28419080)
36. Smith AK, Cenzer IS, Knight SJ, et al: The epidemiology of pain during the last 2 years of life. Ann Intern Med 153:563-569, 2010
37. Takase H, Sakata T, Yamano T, et al: Advantage of early induction of opioid to control pain induced by irradiation in head and neck cancer patients. Auris Nasus Larynx 38:495-500, 2011
38. Murtagh FE, Chai MO, Donohoe P, et al: The use of opioid analgesia in end-stage renal disease patients managed without dialysis: Recommendations for practice. J Pain Palliat Care Pharmacother 21:5-16, 2007 (Pubitemid 47366087)
39. Decker SL, Higginson IJ: A tale of two cities: Factors affecting place of cancer death in London and New York. Eur J Public Health 17:285-290, 2007 (Pubitemid 47356294)
40. Thames Cancer Registry: Cancer in South East England: Cancer incidence, prevalence, survival and treatment for residents of South East England in 2010. http://www.thames-cancer-reg.org.uk/informat/pubs/2010-tcr-report.pdf